Among patients with asthma who received four doses of depemokimab over 2 years, the annualized exacerbation rate was low, ...
Among children, adolescents and adults with peanut allergy, a once-daily peanut sublingual immunotherapy tablet was well tolerated up to the highest dose in an up-dosing regimen, according to phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results